Changes to primary care delivery during the COVID-19 pandemic and perceived impact on medication safety: A survey study.

COVID-19 Community pharmacy General practice Medication safety Primary care

Journal

Exploratory research in clinical and social pharmacy
ISSN: 2667-2766
Titre abrégé: Explor Res Clin Soc Pharm
Pays: United States
ID NLM: 9918266300706676

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 21 02 2022
revised: 27 04 2022
accepted: 27 04 2022
entrez: 15 6 2022
pubmed: 16 6 2022
medline: 16 6 2022
Statut: epublish

Résumé

The COVID-19 pandemic has had a profound impact on the delivery of primary care around the world. In Ireland, the use of technologies such as virtual consultations and the electronic transfer of prescriptions became widespread in order to deliver care to patients while minimising infection risk. The impact of these changes on medication safety is not yet known. The aims of this survey study were to investigate 1) the changes that have occurred in Irish primary care since the start of the COVID-19 pandemic and 2) the impact of these changes on medication safety. Anonymous, online surveys were distributed to general practitioners (GPs) and pharmacists from August-September 2021. Surveys contained quantitative (multiple-choice, Likert scale) and qualitative (free-text) questions concerning workflow changes, medication safety incidents and near misses, and GP/pharmacist perspectives on medication safety and COVID-19. Reported medication safety incidents and near misses were categorised according to the WHO Conceptual Framework for the International Classification for Patient Safety. In total, there were 251 responses to the survey, comprising of 211 pharmacists and 40 GPs. The most significant workflow changes during the pandemic were the widespread use of a secure clinical email service (Healthmail) that facilitates electronic prescription transfer and communication (75.3% of respondents) and the increased use of telephone consultations (49%). Overall, Healthmail was widely perceived to have had a positive impact on medication safety. Most GPs did not perceive a change in the frequency of medication safety incidents during the pandemic, while most pharmacists reported a slight increase in incidents. Survey participants highlighted pressure, patient expectations, and patient monitoring as significant challenges encountered during the pandemic. During the pandemic, a number of significant changes occurred in primary care in Ireland, particularly involving communication of healthcare information, with varying impacts on workflow and medication safety. Future research should focus on the optimisation of electronic prescribing and telemedicine services in Ireland, patient perspectives on the changes in primary care, and interventions to improve medication safety in primary care.

Identifiants

pubmed: 35702683
doi: 10.1016/j.rcsop.2022.100143
pii: S2667-2766(22)00042-7
pmc: PMC9182324
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100143

Informations de copyright

© 2022 Published by Elsevier Inc.

Déclaration de conflit d'intérêts

☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. ☐The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:

Références

Res Social Adm Pharm. 2014 Jul-Aug;10(4):647-55
pubmed: 24139956
Psychol Health. 2022 Feb;37(2):151-177
pubmed: 34187244
Front Psychol. 2021 Jan 27;11:576229
pubmed: 33584412
Br J Gen Pract. 2021 Jul 29;71(709):344-345
pubmed: 34326075
BMJ. 2000 Mar 18;320(7237):768-70
pubmed: 10720363
Pharmacy (Basel). 2021 May 04;9(2):
pubmed: 34064467
Explor Res Clin Soc Pharm. 2022 Mar;5:100104
pubmed: 35072149
BMC Med Inform Decis Mak. 2017 Dec 28;17(1):180
pubmed: 29282048
Eur J Gen Pract. 2021 Dec;27(1):166-175
pubmed: 34282695
Health Policy Technol. 2020 Dec;9(4):419-429
pubmed: 32923355
Health Aff (Millwood). 2018 Nov;37(11):1877-1883
pubmed: 30395495
BMJ. 2020 Mar 12;368:m998
pubmed: 32165352
Lancet. 2017 Apr 29;389(10080):1680-1681
pubmed: 28463129
Inform Prim Care. 2006;14(2):93-9
pubmed: 17059698
Eur J Gen Pract. 2021 Dec;27(1):142-151
pubmed: 34212814
Int J Qual Health Care. 2009 Feb;21(1):2-8
pubmed: 19147595
Int J Med Inform. 2010 Nov;79(11):736-71
pubmed: 20884286

Auteurs

Laura L Gleeson (LL)

School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.

Aoife Ludlow (A)

School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.

Emma Wallace (E)

Department of General Practice, RCSI University of Medicine and Health Sciences, Dublin, Ireland.

Rob Argent (R)

School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.

Claire Collins (C)

Research Unit, Irish College of General Practitioners, Dublin, Ireland.

Barbara Clyne (B)

Department of General Practice, RCSI University of Medicine and Health Sciences, Dublin, Ireland.

Lisa Mellon (L)

Division of Population Health Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.

James W Barlow (JW)

Department of Chemistry, RCSI University of Medicine and Health Sciences, Dublin, Ireland.

Benedict Ryan (B)

School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.

Aoife De Brún (A)

UCD Centre for Interdisciplinary Research, Education and Innovation in Health Systems (UCD IRIS), School of Nursing, Midwifery & Health Systems, University College Dublin, Ireland.

Alice Holton (A)

School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.

Muriel Pate (M)

National Medication Safety Programme, National Quality and Patient Safety Directorate, Health Service Executive, Ireland.

Ciara Kirke (C)

National Medication Safety Programme, National Quality and Patient Safety Directorate, Health Service Executive, Ireland.

Michelle Flood (M)

School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.

Frank Moriarty (F)

School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.

Classifications MeSH